Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS Phosphorylation

<div>Study design of XNJ pretreatment and cerebral ischemia reperfusion injury exposure. (a) XNJ pretreatment and cerebral ischemia reperfusion (I/R) injury exposure in rats; (b) XNJ pretreatment and oxygen-glucose deprivation OGD exposure in human brain microvessel endothelial cells (HBMECs).</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS Phosphorylation 